BridgeBio Oncology Therapeutics (BBOT) Prepaid Assets (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Prepaid Assets of $14.1 million for Q1 2026, up 114.98% sequentially from $6.6 million in Q4 2025, and up 21987.84% YoY from N/an in Q1 2025.
BridgeBio Oncology Therapeutics (BBOT) Prepaid Assets (2024 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported Prepaid Assets for 3 years, with the latest figure at $14.1 million in Q1 2026.
- Quarterly Prepaid Assets rose 21987.84% year-over-year to $14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.1 million (up 21987.84% YoY) and the FY2025 annual result came in at $6.6 million, up 119.72% from the prior year.
- Prepaid Assets advanced to $14.1 million in Q1 2026 per BBOT's latest filing, from $6.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $14.1 million in Q1 2026 and troughed at $6327.0 in Q3 2024.
- A 3-year average of $3.5 million and a median of $150048.0 in 2025 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 118423.79% in 2025, down 119.72% in 2025.
- Over 3 years, Prepaid Assets stood at $3.0 million in 2024, then jumped by 119.72% to $6.6 million in 2025, then surged by 114.98% to $14.1 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $14.1 million, $6.6 million, and $7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BridgeBio Oncology Therapeutics | 726.38 Mn | 500.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.01 Mn |
| Mar 31, 2026 | 14.08 Mn |
| Dec 31, 2025 | 6.55 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 150,048.00 |
| Mar 31, 2025 | 63,750.00 |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | 6,327.00 |
| Jun 30, 2024 | 11,307.00 |
| Mar 31, 2024 | 16,283.00 |